Practice Fusion expands EPCS to additional states
After delivering our e-prescribing for controlled substances (EPCS) system to our New York customers, we’ve been actively working to offer EPCS to practices in all states. We’re excited to announce that providers in the following states now have access to our industry-leading EPCS software:
- **Missouri **
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Rhode Island
- South Carolina
- South Dakota
- West Virginia
Start using our certified e-prescribing software with EPCS
Practice Fusion’s EPCS system is certified and meets all Drug Enforcement Administration (DEA) requirements. Start using EPCS on Practice Fusion and find out why our e-prescribing continues to be ranked #1.
Get started with EPCS »
You’ll need the following to activate EPCS on Practice Fusion:
- A valid DEA number. A valid DEA registration number provides authorization for a prescriber to write prescriptions for controlled substances.
- A smartphone. You’ll e-sign each prescription of a controlled substance using an app on your phone.
What is EPCS?
e-Prescribing of controlled substances, or EPCS, is the electronic transmission of a prescription for controlled substance to a pharmacy. In 2010, the Drug Enforcement Agency’s (DEA) revised its regulations to give physicians the choice of writing prescriptions for controlled substances by paper or through a certified electronic system
As of this year, 49 states and the District of Columbia have approved EPCS for Schedules III through V, and most for Schedule II drugs as well. The states that don’t allow Schedule II drug electronic prescriptions are Kansas and Vermont.
No software to install or new hardware to manage
With no software to install, hardware to manage or licensing fees, our you can get started with our cloud-based e-prescribing software just by signing up.
Find out why we’re rated #1
See why more than 112,000 health care professionals from over 50 specialties rely on Practice Fusion for e-prescribing and more.